Kyorin Holdings Inc
TSE:4569
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Kyorin Holdings Inc
Accounts Receivables
Kyorin Holdings Inc
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kyorin Holdings Inc
TSE:4569
|
Accounts Receivables
¥45.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-2%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Accounts Receivables
¥736.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
4%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Accounts Receivables
¥696B
|
CAGR 3-Years
25%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Accounts Receivables
¥566B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Accounts Receivables
¥317.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Accounts Receivables
¥777.8B
|
CAGR 3-Years
20%
|
CAGR 5-Years
18%
|
CAGR 10-Years
8%
|
|
Kyorin Holdings Inc
Glance View
KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,243 full-time employees. The company went IPO on 2006-03-10. The firm operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. The company also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.
See Also
What is Kyorin Holdings Inc's Accounts Receivables?
Accounts Receivables
45.1B
JPY
Based on the financial report for Dec 31, 2025, Kyorin Holdings Inc's Accounts Receivables amounts to 45.1B JPY.
What is Kyorin Holdings Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
-2%
Over the last year, the Accounts Receivables growth was -1%. The average annual Accounts Receivables growth rates for Kyorin Holdings Inc have been 1% over the past three years , 4% over the past five years , and -2% over the past ten years .
